CONVSGTBP• 12 Months (Normalized)
CON vs GTBP (Concentra Group Holdings Parent Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Oct 5, 2025 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CON Performance $36.21
+75.44%
Concentra Group Holdings Parent Inc.
Normalized Baseline0.00%
GTBP Performance $6.16
+772.52%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-697.08 pts
GTBP outperforming by 697.08 percentage points
CONGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CON GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | CON Price | CON Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $36.21 | +75.44% | $6.16 | +772.52% | -697.08% |
| Oct 02, 2026 | $35.65 | +72.72% | $6.10 | +764.02% | -691.30% |
| Sep 30, 2026 | $35.08 | +69.96% | $- | - | |
| Sep 29, 2026 | $35.34 | +71.22% | $6.88 | +873.80% | -802.58% |
| Sep 28, 2026 | $35.36 | +71.32% | $6.80 | +863.17% | -791.85% |
| Sep 25, 2026 | $35.01 | +69.62% | $6.89 | +875.92% | -806.30% |
| Sep 24, 2026 | $34.62 | +67.73% | $6.83 | +867.42% | -799.69% |
| Sep 23, 2026 | $34.79 | +68.56% | $7.10 | +905.67% | -837.11% |
| Sep 22, 2026 | $34.88 | +68.99% | $- | - | |
| Sep 21, 2026 | $34.77 | +68.46% | $7.18 | +917.00% | -848.54% |
| Sep 18, 2026 | $35.47 | +71.85% | $7.16 | +914.16% | -842.31% |
| Sep 17, 2026 | $35.53 | +72.14% | $7.49 | +960.91% | -888.77% |
| Sep 16, 2026 | $36.37 | +76.21% | $7.81 | +1006.23% | -930.02% |
| Sep 15, 2026 | $35.62 | +72.58% | $9.00 | +1174.79% | -1102.21% |
| Sep 14, 2026 | $35.81 | +73.50% | $11.63 | +1547.31% | -1473.81% |
Page 1 of 17